boots tirzepatide FDA Grants a New Indication for Obesity Management Tirzepatide for Weight Loss -

Research sponsored by Novo Nordisk in patients with type 2 diabetes found that, together with diet and exercise, Ozempic led to an average weight loss of almost 10 pounds, while Rybelsus led to an average weight loss of over eight pounds

This can lead to: Intense, persistent nausea Projective or repetitive vomiting Severe abdominal cramping and bloating Significant dehydration due to the inability to keep fluids down Risk of Hypoglycemia While GLP-1 medications are generally known for having a low risk of causing low blood sugar (hypoglycemia) when used alone, taking excessive amounts changes the equation

For patients and clinicians, the practical takeaway is that retatrutide's side effect profile is broadly similar to existing peptide-based obesity treatments, with the addition of dysesthesia as a novel but generally manageable consideration

Low-impact exercise options keep you active without adding to plantar fascia stress during the recovery period